TMCnet News
Upgrade Alert for United Therapeutics (UTHR)Feb 05, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- United Therapeutics (NASDAQ:UTHR) was upgraded from Hold to Buy at Standpoint Research today. The stock closed yesterday at $53.40 on volume of 1.2 million shares, above average daily volume of 534,000. United Therapeutics (NASDAQ:UTHR) defies analysts with a current price ($53.40) 1.2% above its average consensus price target of $52.75. United Therapeutics shares have support at the 50-day moving average (MA) of $52.54 and additional support at the 200-day MA of $50.94. United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials. In the past 52 weeks, shares of United Therapeutics have traded between a low of $36.55 and a high of $70.74 and closed yesterday at $53.40, which is 46% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has risen 0.4%. SmarTrend recommended that subscribers consider buying shares of United Therapeutics on November 20th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $50.89. Since that recommendation, shares of United Therapeutics have risen 4.9%. We continue to monitor UTHR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |